Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Phuphanich

Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma.

Journal of Clinical Oncology

English

Related publications

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Journal of Neuro-Oncology

English

Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

English

Meningioma Imitating Progressive Aphasia

Journal of the Korean Neurological Association

2020

English

A Phase II Study of Axalimogene Filolisbac for Patients With Previously Treated, Unresectable, Persistent/Recurrent Loco-Regional or Metastatic Anal Cancer

Oncotarget

Oncology

2020

English

Phase II Evaluation of Intravenous Vinorelbine (Navelbine) in Recurrent or Refractory Pediatric Malignancies: A Children's Oncology Group Study

Pediatric Blood and Cancer

English

Phase II Evaluation of Dasatinib in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

English

Erratum To: Pasireotide LAR Maintains Inhibition of GH and IGF-1 in Patients With Acromegaly for Up to 25 Months: Results From the Blinded Extension Phase of a Randomized, Double-Blind, Multicenter, Phase III Study

English

A Retrospective Study on Combination Therapy With Ifosfamide, Adriamycin and Cisplatin for Progressive or Recurrent Uterine Sarcoma

Molecular and Clinical Oncology

Cancer Research

Oncology

2014

English

A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. Phuphanich

Phase II Study of Monthly Pasireotide LAR (SOM230C) for Recurrent or Progressive Meningioma.

Related publications

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Meningioma Imitating Progressive Aphasia

A Phase II Study of Axalimogene Filolisbac for Patients With Previously Treated, Unresectable, Persistent/Recurrent Loco-Regional or Metastatic Anal Cancer

Phase II Evaluation of Intravenous Vinorelbine (Navelbine) in Recurrent or Refractory Pediatric Malignancies: A Children's Oncology Group Study

Phase II Evaluation of Dasatinib in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study

Erratum To: Pasireotide LAR Maintains Inhibition of GH and IGF-1 in Patients With Acromegaly for Up to 25 Months: Results From the Blinded Extension Phase of a Randomized, Double-Blind, Multicenter, Phase III Study

A Retrospective Study on Combination Therapy With Ifosfamide, Adriamycin and Cisplatin for Progressive or Recurrent Uterine Sarcoma

A Phase II Evaluation of Lapatinib in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study